Tag: pulmonary embolism

First patient enrolled in STORM-PE RCT evaluating Penumbra’s Lightning Flash for...

Penumbra today announced that the first patient has been enrolled in STORM-PE, a prospective, multicentre, randomised controlled trial (RCT) evaluating anticoagulation alone versus anticoagulation...

Computer-assisted vacuum thrombectomy system for patients with pulmonary embolism demonstrates ‘rapid,...

Patients undergoing computer-assisted vacuum thrombectomy with the Indigo Aspiration System (Penumbra) for pulmonary embolism (PE) showed 2.7% rates of both major adverse events (MAEs)...

E2 shares positive initial results from use of Hēlo system for...

Endovascular Engineering (E2) has announced positive initial results from its ENGULF study, demonstrating successful outcomes among the first 15 patients evaluated in the trial...

Study provides insights from US cohort of FLASH registry for high-risk...

New research from the FLASH registry shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism. The study, titled "Mechanical thrombectomy for high-risk pulmonary embolism:...
Akura

Akura thrombectomy system for PE appears safe and demonstrates reduction of...

Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...
EkoSonic

REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system...

Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism...

Thrombolex announces new insights from the RESCUE trial with the Bashir...

Thrombolex has announced never-before-reported major reductions in obstruction in all of the segmental pulmonary arteries (PA), based on independent core lab data analysis of...

The pulmonary arterial tree—it is time we branch out

Nicolas J Mouawad (McLaren Health System, Bay City, USA) urges vascular surgeons to “get out of their comfort zone” and become more involved in...

“Vascular surgery should be a key member of pulmonary embolism response...

“PERT care is the coalition of the willing,” quipped Dennis Gable, a vascular surgeon at Texas Vascular Associates in Plano, USA. He was referring...

FLAME, FLASH and ongoing PEERLESS trials collect “compelling” data for FlowTriever...

Speaking on the FLAME, FLASH and PEERLESS trials that each collected data on the FlowTriever (Inari Medical) device for the treatment of pulmonary embolism...
filters

New study demonstrates IVC filters “safe and effective” in treating venous...

Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...

Cardiovascular Systems announces US FDA 510(k) submission of Innova Vascular’s thrombectomy...

Cardiovascular Systems (CSI) announced that Innova Vascular (Innova) has submitted a 510(k) premarket notification to the US Food and Drug Administration (FDA) for its...

Penumbra and Asahi Intecc partner to introduce Indigo System to Japan

Penumbra and Asahi Intecc, a Japanese medical device manufacturer, announced that they will collaborate to introduce Penumbra’s Indigo Aspiration System into the Japanese market...

Penumbra announces the European launch of the Indigo system with Lightning...

Penumbra has announced that its Indigo aspiration system with Lightning 7 and Lightning 12 have secured CE mark and are now commercially available in...
Cordis

Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...

Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...

First patient enrolled in PEERLESS study of FlowTriever system

Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomised controlled trial (RCT) comparing the outcomes of patients with...
Viz.ai

Viz.ai launches AI-powered modules for pulmonary embolism and aortic disease

Viz.ai has announced the US commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at VEITHsymposium 2021 (16–20 November, Orlando, USA), the...
EkoSonic

Positive data for the EkoSonic endovascular system presented at VIVA 2021

Boston Scientific announced positive results for the EkoSonic endovascular system (EKOS system) during a late-breaking clinical trial presentation at Vascular Interventional Advances (VIVA) 2021...
EkoSonic

Boston Scientific initiates randomised controlled trial for the EkoSonic endovascular system

Boston Scientific has commenced enrolment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the...

Viz.ai and Avicenna.AI partner to launch AI-driven intelligent care coordination for...

Viz.ai has partnered with Avicenna.AI to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease. Avicenna.AI’s US...

AI triage solution for PE and aortic dissection receives FDA clearance...

Medical imaging artificial intelligence (AI) specialist Avicenna.AI recently announced that it has received certification in the USA and European Union (EU) for CINA CHEST,...

Penumbra’s newest generation of Indigo aspiration system receives FDA clearance for...

Penumbra today announced US Food and Drug Administration (FDA) 510(k) clearance for expanded indication of the latest iteration of the Indigo aspiration system, Lightning...

“Competing safety profiles” of PE devices muddies decision-making

 “There has been a steady change in the approach and care of pulmonary embolisms that has been noted over the last five to seven...

Similar outcomes for ultrasound-assisted and standard thrombolysis in SUNSET sPE

Efthymios Avgerinos (University of Pittsburgh, Pittsburgh, USA) presented results from the SUNSET sPE trial during a late-breaking data session at this year’s Vascular Interventional...

FDA clearance granted to Penumbra for Indigo Aspiration System

Penumbra has announced US Food and Drug Administration (FDA) 510(k) clearance for expanded indication of the Indigo Aspiration System. As part of the system,...

Insera announces first-in-human treatment of patient with PE using CLEAR aspiration...

Insera Therapeutics announced recently that the first patient with acute pulmonary embolism has been treated with its flagship cyclical aspiration system, CLEAR. Earlier last...
Akhilesh Sista Video

New trial planned to rigorously test catheter-directed thrombolysis for submassive PE...

Clinically relevant outcomes are needed to measure catheter-directed therapy (CDT) against anticoagulation alone to treat submassive pulmonary embolism (PE) patients. Further, CDT’s ability to...

VIVA 2019: Penumbra Indigo Aspiration system IDE trial for acute PE...

Penumbra today announced that the EXTRACT-PE trial successfully met the primary endpoints, demonstrating the safety and efficacy of the Indigo Aspiration system for aspiration...

Thrombus dissolution with EKOS™ Acoustic Pulse Thrombolysis™ in everyday clinical practice

 At the EKOS symposium at LINC 2019, Nils Kucher (Zurich, Switzerland), Houman Jalaie (Aachen, Germany) and Mert Dumantepe (Istanbul, Turkey) share their experiences in...
BTG

BTG acquires Novate Medical

BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...

Endobronchial forceps effective in retrieval of tip-embedded inferior vena cava filters

Leaving the devices in place risks filter fracture or symptoms from penetration of filter components outside of the vein into adjacent structures, increased risk of new blood clots in the legs, and other complications.